CANSINOBIO Tetanus Vaccine New Drug Application ApprovedAASTOCKS News·1 day ago, 08:21 AM06185-8.05%688185+20.01%
CanSino Biologics says China NMPA approves adsorbed tetanus vaccine NDAPUBT·1 day ago, 05:43 AM06185-8.05%688185+20.01%
CANSINOBIO Shares Surge on Moderna Positive Phase III mRNA Cancer Vaccine Trial ResultsAASTOCKS News·1 day ago, 01:51 AMMRNA+8.86%MRNX+17.79%
CanSinoBIO spotlights meningococcal vaccine strategy at Asian pediatric infectious diseases congressPUBT·Aug 18 at 08:11 AM06185-8.05%688185+20.01%
CanSinoBIO's NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine PipelineAsian Corporate Newswire·Aug 16 at 07:24 AM06185-8.05%688185+20.01%
CanSino’s Td5cp Booster Wins Priority Review After NDA Acceptance in ChinaTip Ranks·Aug 16 at 05:07 AM06185-8.05%688185+20.01%
CanSino says China regulator accepts NDA for TD5CP booster vaccine, grants priority reviewPUBT·Aug 16 at 05:04 AM06185-8.05%688185+20.01%
CanSinoBIO signs LOI with Pakistan’s AGP to explore PCV13i vaccine opportunitiesPUBT·Jul 21 at 12:26 AM688185+20.01%06185-8.05%
CanSino says China regulator accepts Menhycia label expansion filing to age 17PUBT·Jul 19 at 05:08 AM06185-8.05%688185+20.01%
CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South AmericaAsian Corporate Newswire·Jun 29 at 04:21 AM06185-8.05%688185+20.01%
CanSino Biologics, Inc. Class H (6185) Receives a Buy from UBSTip Ranks·Jun 26 at 07:26 PM06185-8.05%
CanSino Wins Argentine Approval for Menhycia Vaccine as Global Push AcceleratesTip Ranks·Jun 25 at 04:40 AM688185+20.01%06185-8.05%
